FCGR2A and FCGR3A polymorphisms and response to rituximab treatment in patients with B-cell chronic lymphocytic leukemia. - Angelovic R; Pavkovic M; Panovska Stavridis I; Arangelovic E; Trajkova S; Cadievski L; Stojanovic A (My University, 2019)